Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / COMMON STOCK, PAR V ALUE $0.001 PER SHARE
-
Shares outstanding
-
74.9M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
6.73M
-
Shares change
-
+138K
-
Total reported value, excl. options
-
$42.4M
-
Value change
-
+$1.36M
-
Put/Call ratio
-
2.96
-
Number of buys
-
36
-
Number of sells
-
-13
-
Price
-
$6.30
Significant Holders of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) as of Q2 2020
77 filings reported holding CRMD - CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE as of Q2 2020.
CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.73M shares
of 74.9M outstanding shares and own 8.98% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.78M shares), VANGUARD GROUP INC (1.22M shares), Elliott Investment Management L.P. (833K shares), STATE STREET CORP (478K shares), GEODE CAPITAL MANAGEMENT, LLC (363K shares), Cresset Asset Management, LLC (330K shares), NORTHERN TRUST CORP (328K shares), Nuveen Asset Management, LLC (122K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (98.1K shares), and Bank of New York Mellon Corp (92.2K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.